Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy
2013
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Heart Failure Outcomes in Clinical Trials of Glucose-Lowering Agents in Patients with Diabetes
2016
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
1999 Standout
Evaluation of left ventricular outflow tract gradient during treadmill exercise and in recovery period in orthostatic position, in patients with hypertrophic cardiomyopathy
2008
Sarcomeric hypertrophic cardiomyopathy: Genetic profile in a Portuguese population
2012
Efficacy of magnesium sulfate in the treatment of torsade de pointes
1986
Optimal Administration Dosage of Magnesium Sulfate for Torsades de Pointes in Children with Long QT Syndrome
2004
Magnesium deficiency in coronary artery disease and cardiac arrhythmias
1989
Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction
2007
Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis
1992
Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing
2013
Treatment of tachyarrhythmias during pregnancy and lactation
2001
Evaluation of Diastolic Filling of Left Ventricle in Health and Disease: Doppler Echocardiography Is the Clinician’s Rosetta Stone
1997
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)
1999
Standing and Exercise Doppler Echocardiography in Obstructive Hypertrophic Cardiomyopathy: The Range of Gradients with Upright Activity
2010
Timing and Significance of Exercise-Induced Left Ventricular Outflow Tract Pressure Gradients in Hypertrophic Cardiomyopathy
2010
Postinfarction Use of β-Blockers in Elderly Patients
1997
Perioperative myocardial ischemia in patients undergoing noncardiac surgery—I: Incidence and severity during the 4 Day perioperative period
1991
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
2013 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes
2005
Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1
2018
Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease
2003
Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study)∗∗The views expressed in this study are those of the authors and do not necessarily reflect those of the Indian Health Service.
2001
Cushing's syndrome
2015 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Transesophageal echocardiography in patients with recent stroke and normal carotid arteries
2001
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
Magnesium causes nitric oxide independent coronary artery vasodilation in humans
2001
Exercise Standards for Testing and Training
2013 Standout
Prognosis and Management after a First Myocardial Infarction
1990
Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke
2004
Dilated cardiomyopathy
2010
Inherited Cardiomyopathies
2011
Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography
2012
Systemic sclerosis
2017 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy
2009
The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy
2011
Therapeutic and diagnostic efficacy of adenosine in wide-complex tachycardia
1993
Assessment of Left Ventricular Outflow Gradient
2012
Nicotine replacement therapy for smoking cessation
2008
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease
2000
Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists
2013
Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging
2009
Anesthesiology
1997 Standout
Review and Metaanalysis of the Frequency of Familial Dilated Cardiomyopathy
2011
Magnesium in disease
2012
Acute kidney injury
2019 Standout
Clinical and genetic issues in familial dilated cardiomyopathy
2005
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis
1993
Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment
2010
Tissue Doppler Imaging and Plasma BNP Levels to Assess the Prognosis in Patients with Hypertrophic Cardiomyopathy
2011
Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
2012
Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both
2001 Standout
Left ventricular non-compaction revisited: a distinct phenotype with genetic heterogeneity?
2011
Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes
2008
Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery
1993
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
2013
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Role of Magnesium in Reducing Mortality in Acute Myocardial Infarction
1993
ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome
1989
Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: Periprocedural results and midterm risk of recurrent neurologic events
2008
Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome
2006
Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years
2011
Burden of valvular heart diseases: a population-based study
2006 Standout
Treatment of cardiac arrhythmias during pregnancy
1993
Echocardiographic findings in fulminant and acute myocarditis
2000
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
1993
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
1992
A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel
1995 Standout
Cardiogenic and Aortogenic Brain Embolism
2008
Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
2001
Obesity and the Risk of Heart Failure
2002 Standout
Usefulness of Magnetic Resonance Imaging to Distinguish Hypertensive and Hypertrophic Cardiomyopathy
2010
Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population
2007
Myocardial Reperfusion Injury
2007 Standout
Fine Particulate Matter Air Pollution, Proximity to Traffic, and Aortic Atherosclerosis
2009
A new method for quantification of left ventricular systolic function using a corrected ejection fraction
2011
Cardiomyopathies: is it time for a molecular classification?
2004
Primary and Secondary Prevention of Cardiovascular Disease
2012
Clinical relevance of cardiac arrhythmias generated by afterdepolarizations
1994
Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting
2001
Novel therapeutics for treatment of long-QT syndrome and torsade de pointes
2004
Identification of patent foramen ovale permitting paradoxic embolism
1995
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
2011
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial
2010
Left Ventricular Outflow Tract Gradient Provoked by Upright Position or Exercise in Treated Patients with Hypertrophic Cardiomyopathy without Obstruction at Rest
2009
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
2010
Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander?
2004
Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations?
1989
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Familial dilated cardiomyopathy
1994
Left Ventricular Dilatation and the Risk of Congestive Heart Failure in People without Myocardial Infarction
1997
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Cellular and Ionic Mechanisms Underlying Erythromycin-Induced Long QT Intervals and Torsade de Pointes
1996
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
1995 Standout
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
2003 Standout
Circadian Rhythm of Appropriate Implantable Cardioverter Defibrillator Discharges in Patients with Hypertrophic Cardiomyopathy
2008
Reflections of Inflections in Hypertrophic Cardiomyopathy
2009
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
2009
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases
2014
Prevalence and correlates of aortic regurgitation in american indians: the Strong Heart Study
2000
The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events
2000
Myocarditis
2009 Standout
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Diagnosis and treatment of diseases of the aorta
1997
Systematic review of pregnancy in women with inherited cardiomyopathies
2011
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
2010 Standout
Recurrent cerebral ischemia in medically treated patent foramen ovale
2009
Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient?
1987
Exercise Testing in Nonatherosclerotic Heart Disease
2011
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
1996
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy
2012
The Frequency of Familial Dilated Cardiomyopathy in a Series of Patients with Idiopathic Dilated Cardiomyopathy
1992
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
Nicotine replacement therapy for smoking cessation
2012 Standout
A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations
2013
Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children
2007
Magnesium in Man: Implications for Health and Disease
2014 Standout
Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
1989
Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy
2012
Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades
2013
Patent Foramen Ovale in Young Adults with Unexplained Stroke
2005
Long-term Cardiac Prognosis Following Noncardiac Surgery
1992
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum
2012
Recurrent stroke on imaging and presumed paradoxical embolism
2012
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias
1983
Mitral and Aortic Annular Calcification Are Highly Associated With Systemic Calcified Atherosclerosis
2006
Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
2000
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)
2000 Standout
Reperfusion-induced arrhythmias: Mechanisms and prevention
1984
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Intravenous magnesium for acute myocardial infarction
2007
Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
1997 StandoutNobel
Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging
2010
Cardiac abnormalities in familial palmoplantar keratosis.
1986
Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care
1986
Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli
2003
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention
2009
Biosynthesis of Apolipoprotein B48-containing Lipoproteins
1996 StandoutNobel
Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy
2015
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Significant Association of Atrial Vulnerability With Atrial Septal Abnormalities in Young Patients With Ischemic Stroke of Unknown Cause
2000
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures
2000 Standout
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping
2013
Occurrence of Secondary Ischemic Events Among Persons With Atherosclerotic Vascular Disease
2002
Electrocardiographic Abnormalities and Serum Magnesium in Patients With Subarachnoid Hemorrhage
2004
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation
2002
Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic Cardiomyopathy
2013
Congestive Heart Failure With Normal Left Ventricular Systolic Function
1996
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Proarrhythmic effects of antiarrhythmic drugs
1987
Alternatively activated macrophages determine repair of the infarcted adult murine heart
2016
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Part 8: Adult Advanced Cardiovascular Life Support
2010 Standout
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale
2002
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Incidence, Pathophysiology, and Treatment of Complications During Dobutamine-Atropine Stress Echocardiography
2010
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
1994
Genetic Biomarkers in Hypertrophic Cardiomyopathy
2013
ATP-sensitive potassium channel (K ATP )–dependent regulation of cardiotropic viral infections
2011 StandoutNobel
Works of Andre Keren being referenced
Impaired Fasting Glucose: A Predictor of Reduced Survival in Patients with Heart Failure
2014
Use of Streptokinase for Lysis of a Mobile Left Ventricular Thrombus - Report of a Case and Review of the Literature
1988
Frequency and Distribution of Atherosclerotic Plaques in the Thoracic Aorta as Determined by Transesophageal Echocardiography in Patients With Coronary Artery Disease
1997
The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy
2008
The effect of disopyramide on uterine contractions during pregnancy
1990
The value of changes in QRS width and in ST-T segment during exercise test in hypertrophic cardiomyopathy for identification of associated coronary artery disease
2005
Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression
2008
Characteristics of silent and symptomatic myocardial ischemia during daily activities
1988
Impact of Age on the Safety and the Hemodynamic Response Pattern During High Dose Dobutamine Echocardiography
1999
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy
2007
Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
2008
Natural history of left ventricular thrombi: Their appearance and resolution in the posthospitalization period of acute myocardial infarction
1990
Lysis of mobile left ventricular thrombi during acute myocardial infarction with urokinase
1987
Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: A double-blind study in healthy smokers
1996
Prognostic significance of ischemic episodes in patients with previous myocardial infarction
1988
Magnesium Therapy in Ventricular Arrhythmias
1990
Suppression of ventricular arrhythmias by magnesium
1990
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
2010
The prevalence of valvular regurgitation in children with structurally normal hearts: A color Doppler echocardiographic study
1992
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
2007 Standout
Relation of Coronary Artery Disease to Atherosclerotic Disease in the Aorta, Carotid, and Femoral Arteries Evaluated by Ultrasound
1997
Doppler echocardiographic patterns of left ventricular filling in patients early after acute myocardial infarction
1992
Cardiovascular Safety of Transdermal Nicotine Patches in Patients with Coronary Artery Disease who Try to Quit Smoking
1998
Usefulness of Predischarge Echocardiographic Criteria in Predicting Complications following Acute Myocardial Infarction
1986
Mildly dilated congestive cardiomyopathy.
1985
Assignment of patients into the classification of cardiomyopathies.
1992
ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008
2009
Comparative recognition of left ventricular thrombi by echocardiography and cineangiography.
1985
Echocardiographic recognition and implications of ventricular hypertrophic trabeculations and aberrant bands.
1984
Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina
1983
Ventricular pacing in atypical ventricular tachycardia
1981
Accuracy of biplane and multiplane transesophageal echocardiography in diagnosis of typical acute aortic dissection and intramural hematoma
1996
Treatment of torsade de pointes with magnesium sulfate.
1988
Atypical Ventricular Tachycardia (Torsade de Pointes) Induced by Amiodarone
1982
Myocardial ischemia during daily activities and stress
1986
Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation.
1990
Echocardiographic recognition of paraseptal structures
1985
Circadian variations in ischemic threshold and their relation to the occurrence of ischemic episodes.
1993
Atrial Septal Aneurysm in Adult Patients
1995
Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients.
1981
Torsades de pointes versus polymorphous ventricular tachycardia
1983
Magnesium therapy for torsades de pointes
1984